Clinical trials
Hemorrhagic Disorders trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Takeda | 2 |
| Children's Hospital of Fudan University | 1 |
| Pfizer | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shenzhen University General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhagic Disorders | 8 |
| Hematologic Diseases | 6 |
| Immune System Diseases | 4 |
| Autoimmune Diseases | 2 |
| Blood Coagulation Disorders | 2 |
| Blood Coagulation Disorders, Inherited | 2 |
| Blood Platelet Disorders | 2 |
| Blood Protein Disorders | 2 |
| Cardiovascular Diseases | 2 |
| Coagulation Protein Disorders | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.